Skip to main content

Evernow vs Clue for Perimenopause: Telehealth vs Self-Tracking

Last updated: March 21, 2026

TLDR

Evernow and Clue are not direct competitors — Evernow provides medical treatment through licensed clinicians at $49/month, while Clue provides self-tracking tools on an ad-supported free model. Comparing them only makes sense if you are deciding between medication and self-monitoring.

Feature Evernow Clue Horiva
Monthly cost $49/mo telehealth subscription Free + $14.99/mo $9/mo
Privacy model Data monetization Data monetization On-device only
Perimenopause focus General General Perimenopause-first
Doctor reports No No Yes — PDF export
Evernow vs Clue Feature Comparison
FeatureEvernowClueHoriva
Monthly cost$49/moFree / $14.99$9/mo (trial)
Clinical careYes — licensed cliniciansNoNo (tracking only)
Perimenopause focusTreatment-focusedGeneral period trackerBuilt for perimenopause
Data privacy modelHIPAA-coveredAd-supportedOn-device only
Doctor reportsInternal records onlyNoYes — PDF export

Two Different Products

Comparing Evernow to Clue is like comparing a specialist clinic to a health diary. They are different categories. Evernow is a telehealth platform — licensed clinicians assess your symptoms and prescribe treatment. Clue is a self-tracking app where you log data yourself and view patterns.

The reason this comparison appears at all is that women researching perimenopause options encounter both products and need to understand where each fits.

When You Need Clinical Care

Evernow, Midi, Alloy, and similar telehealth platforms exist because perimenopause symptoms can significantly impair quality of life and often respond well to hormone therapy. Night sweats severe enough to disrupt sleep, vasomotor symptoms that interfere with work, mood changes that affect relationships — these are clinical problems that benefit from clinical management.

Clue cannot treat any of these. It can log them.

When Self-Tracking Is Enough

Some women in early perimenopause have mild symptoms and want to understand patterns before deciding on treatment. Self-tracking makes sense here — document what is happening, identify triggers, build a symptom history to bring to a doctor appointment.

Clue can do this, but its ad-supported model means health data is processed for advertising purposes. The tracking functions work; the privacy model may not meet every user’s threshold.

Where Horiva Fits

Horiva is in the self-tracking category, not the telehealth category. It is built specifically for perimenopause — irregular cycles, hot flash patterns, sleep disruption, brain fog — and stores all data on-device. The PDF export is designed to work alongside clinical care, whether that is Evernow, a traditional OB/GYN, or a menopause specialist.

Neither option feel right?

Most women pay for features they don't use. Horiva is $9/mo with no data selling — ever.

Verdict

These two products do not overlap. Evernow is for women who want medical treatment for perimenopause symptoms. Clue is for women who want to track their cycles. If you are experiencing significant perimenopause symptoms and want clinical guidance, Evernow is the category; Clue is not.

PROS & CONS

Evernow

Pros

  • Actual medical treatment — clinicians can prescribe HRT
  • HIPAA-covered data handling as a healthcare provider
  • Personalized treatment plans based on symptom severity

Cons

  • $49/mo is before prescription medication costs
  • Telehealth model means no physical exam
  • State availability limitations

PROS & CONS

Clue

Pros

  • Free basic tracking with no upfront cost
  • Clean app design with consistent updates
  • Research credibility from academic partnerships

Cons

  • Ad-supported free tier means health data contributes to revenue
  • No clinical guidance — purely self-tracking
  • Cycle predictions assume regularity

Q&A

Is Evernow worth $49 per month for perimenopause?

Evernow provides access to licensed clinicians who can prescribe hormone replacement therapy and other treatments. For women with significant perimenopause symptoms who want medical management, $49/mo for telehealth access is comparable to or less expensive than traditional out-of-pocket specialist visits. The cost does not include prescription medications, which are filled through a pharmacy.

Q&A

Can Clue help with perimenopause symptoms?

Clue can log symptoms and provide a basic pattern overview. It does not offer clinical guidance, cannot suggest treatment options, and its cycle predictions become less accurate with irregular cycles. For symptom documentation, Clue works. For actual treatment, Clue is the wrong tool.

Q&A

What does Evernow actually do?

Evernow connects US women with licensed clinicians who specialize in menopause treatment. After an intake assessment, a clinician reviews your symptom history and can prescribe HRT (estrogen, progesterone, or combination therapy) or non-hormonal treatments. Follow-up appointments and prescription management are included in the subscription.

Is Evernow available in my state?
Evernow is not available in all US states due to telehealth licensing requirements. Check the Evernow website for current state availability before subscribing.
Does Clue have a menopause-specific mode?
Clue has added some perimenopause-related content and symptom categories, but the app is fundamentally a cycle tracker. There is no dedicated perimenopause mode that adjusts predictions for irregular cycles.
How does Horiva fit between Evernow and Clue?
Horiva is a perimenopause-specific symptom tracker with on-device data storage and doctor report export. It does not provide clinical care like Evernow, but it is purpose-built for the perimenopause transition in a way Clue is not. Women using Evernow can use Horiva to log symptoms between appointments and share a structured report at each telehealth visit.

Related Comparisons